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Background: Individuals with mental illnesses are overrepresented among the homeless. Housing First (HF) has
been shown to promote positive outcomes in this population. However, key questions remain unresolved,
including: how to match support services to client needs, the benefits of housing in scattered sites versus single
congregate building, and the effectiveness of HF with individuals actively using substances. The present study
aimed to recruit two samples of homeless mentally ill participants who differed in the complexity of their needs.
Study details, including recruitment, randomization, and follow-up, are presented.
Methods: Eligibility was based on homeless status and current mental disorder. Participants were classified as either
moderate needs (MN) or high needs (HN). Those with MN were randomized to HF with Intensive Case Management
(HF-ICM) or usual care. Those with HN were randomized to HF with Assertive Community Treatment (HF-ACT),
congregate housing with support, or usual care. Participants were interviewed every 3 months for 2 years. Separate
consent was sought to access administrative data.
Results: Participants met eligibility for either MN (n = 200) or HN (n = 297) and were randomized accordingly. Both
samples were primarily male and white. Compared to participants designated MN, HN participants had higher rates of
hospitalization for psychiatric reasons prior to randomization, were younger at the time of recruitment, younger when
first homeless, more likely to meet criteria for substance dependence, and less likely to have completed high school.
Across all study arms, between 92% and 100% of participants were followed over 24 months post-randomization.
Minimal significant differences were found between study arms following randomization. 438 participants (88%) provided
consent to access administrative data.
Conclusion: The study successfully recruited participants meeting criteria for homelessness and current mental disorder.
Both MN and HN groups had high rates of substance dependence, suicidality, and physical illness. Randomization
resulted in no meaningful detectable differences between study arms.
Trial registration: Current Controlled Trials: ISRCTN57595077 (Vancouver at Home study: Housing First plus Assertive
Community Treatment versus congregate housing plus supports versus treatment as usual) and ISRCTN66721740
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Individuals who are homeless and mentally ill are het-
erogeneous in their health and social challenges. Effect-
ive models of service must be responsive to individual
needs, which may vary across time and space, and are
constrained by pragmatic factors, including local standards
of care, housing availability, and funding. The Vancouver
At Home (VAH) project has implemented two random-
ized controlled trials (RCTs) involving homeless mentally
ill adults in Vancouver, BC, Canada. VAH is collaborating
with similar projects in four other Canadian cities [1].
Each collaborating center has incorporated a common
methodology, with pragmatic adaptations in each site.
Site-specific adaptations were influenced by the character-
istics of each local population (for example, ethno-racial
services in Toronto, ON, Aboriginal focus in Winnipeg,
MB), as well as the structural features of each locale (for
example, rural service models in Moncton, NB, congregate
housing in Vancouver, BC). The purpose of the present
article is to describe the unique features of VAH, including
measures, interventions, and sample characteristics in ac-
cordance with the Consolidated Standards of Reporting
Trials (CONSORT) statement for the reporting of prag-
matic trials.
We briefly describe the physical setting of Vancouver,
the local population who are both homeless and men-
tally ill, and the Housing First (HF) program. These fac-
tors influenced both the design and implementation of
VAH with the goal of maximizing the effectiveness and
relevance of the project.
For decades, the city of Vancouver has struggled to
meet the needs of a visibly homeless and inadequately
sheltered population in a central downtown neighbor-
hood. The same neighborhood has been afflicted by high
crime rates, an open market for illicit drugs, infectious
diseases, and premature mortality [2]. For many years,
the most affordable housing in the neighborhood has
consisted of single room occupancy (SRO) hotels, many
of which earned a reputation for hazards ranging from
bed bugs to criminal predation [3,4]. Individuals with
mental illness are prominent among the homeless,
particularly following ‘deinstitutionalization’, whereby
regional psychiatric facilities were downsized as prom-
ises to implement community-based support, such as
Assertive Community Treatment (ACT), were unful-
filled. A diverse array of services emerged over time
to support individuals in the neighborhood, including
outreach services, meal programs, shelters, drug-related
services (for example, needle exchange, supervised
injection site [5]), and varied forms of supported
housing.
The City of Vancouver has implemented a plan with
the goal to ‘end street homelessness’ by 2015. A key
element of the plan involves the construction ofapartment buildings to provide housing and support for
the homeless. However, key questions remain unresolved
regarding the appropriate mix of occupants in these
buildings and the type of support that would be required
to promote stable occupancy and recovery among indi-
viduals who are leaving homelessness and who have dif-
fering needs.
Prior to VAH, no study had systematically examined
the health and housing status of individuals who were
homeless and mentally ill in Vancouver. A considerable
amount of anecdotal and descriptive information was
available from sources, such as shelter operators, street
outreach clinicians, police, and from research involving
samples that included homeless individuals (for example,
patients with HIV/AIDS, survival sex workers [4,6,7]).
The available evidence suggests that the local population
of homeless mentally ill individuals struggles with com-
plex social and medical problems, including infectious
diseases, frequent polysubstance use, cognitive impair-
ment, trauma, victimization, and poor food security
[4,8]. It had also been reported that homeless individuals
were using emergency and hospital services due to inad-
equate community care, and were frequently involved
with the justice system [7,9]. Based on these consider-
ations, it was anticipated that VAH would extend the HF
model to clients with more complex needs than those
described in previous trials, including participants with
concurrent substance use disorders.
A growing literature supports the effectiveness of the
HF model for individuals who are both homeless and
mentally ill. HF emphasizes the value of client choice
and has been shown to promote residential stability
[10,11], community integration [12], and high levels of
client satisfaction [13]. Originating from the Pathways
model in New York City, NY, USA, HF involves building
a portfolio of rental accommodations (typically apart-
ments) scattered throughout different neighborhoods,
thereby providing clients with meaningful choices con-
cerning the location and setting of their residence [14].
Clients are then supported in their homes by either an
HF with Assertive Community Treatment (HF-ACT)
team or HF with Intensive Case Management (HF-ICM),
depending on their level of needs. ACT was originally
created to constitute a ‘hospital without walls’ enabling
individuals who might otherwise have been admitted to
psychiatric facilities to instead pursue recovery in com-
munity settings [15]. ACT teams are available 24/7, and
include varied expertise across multiple disciplines. The
effectiveness of ACT has been well established among
individuals who reflect the original target population
(that is, individuals with psychotic disorders or bipolar
disorder), including specific outcomes, such as reduc-
tions in hospital admissions and criminal justice involve-
ment [16,17]. However, the effectiveness of HF-ACT is
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cognitive impairments, complex addictions, or multiple
physical and mental illnesses.
The majority of studies examining HF have followed
participants for up to 24 months (for example, Gulcur
[11], Tsemberis and Eisenberg [14]). Longer-term re-
search involving diverse residential interventions for
homeless individuals in New York City found that hous-
ing stability decreased after 1, 2, and 5 years (75%, 64%,
and 50%, respectively) [18]. Several studies have reported
that substance use disorders are predictive of lower
housing stability regardless of residence type [19,20].
Preliminary evidence suggests that congregate HF (that
is, a single supported building) may achieve housing sta-
bility and cost savings among homeless men who are al-
cohol dependent [21]. However, it is not known whether
these results would be replicated among mentally ill
users of illicit (or multiple) substances and who receive
scattered site HF.
Compared to ACT, the effectiveness of ICM has re-
ceived less empirical attention in the context of sup-
ported housing for individuals with mental illness, and
its definition varies widely [22]. Unlike HF-ACT, which
provides a broad range of specialized services directly to
clients, HF-ICM operates as a liaison connecting clients
with community services based on their expressed
needs. The success of HF-ICM is therefore a function of
the complexity of client needs, as well as the availability
and appropriateness of relevant community resources.
HF-ICM may be appropriate for clients with less severe
mental illness or as a step-down from HF-ACT following
successful stabilization. For example, as part of a multi-
center trial, the Boston McKinney study [22] random-
ized homeless adults with mental illness to independent
apartments or small group homes, both of which re-
ceived ‘comprehensive case management’. Findings indi-
cated that housing availability, regardless of type, was
the primary predictor of subsequent ability to avoid
homelessness, while enhanced services reduced the
risk of homelessness if housing was also available.
Substance abuse was the strongest single predictor of
days homeless [22,23].
The primary objectives of this article are:
1. To report study details including measures and
interventions that are unique to VAH.
2. To present details of recruitment and follow-up
rates for participants in VAH including primary data
collection and administrative data.
3. To present baseline characteristics and examine
potential non-equivalence between randomization
arms in each trial.
4. To examine differences in the complexity of needs
between participants in the two trials.Methods
Community engagement
Development of the research protocol was preceded by
several community meetings and by six focus groups
with individuals who had experienced homelessness and
mental illness in the Vancouver area. In total, 58 individ-
uals were convened with the assistance of community
agencies, and met privately with an experienced aca-
demic facilitator who took notes and prepared reports of
proceedings. Focus group participants were asked to ad-
vise on procedures to enhance the relevance of the re-
search, to minimize risks and maximize benefits to
participants, and ways to incorporate the expertise of in-
dividuals with direct experiences of homelessness in the
research project. Narrative feedback from respondents
(for example, amounts of honoraria, the need to include
individuals who had experienced homelessness as mem-
bers of service teams and on the research team) were in-
cluded in the grant application and later implemented as
part of the project. Service provider representatives were
consulted extensively during the design of the research
and were invited to respond to a request for proposals
to implement the major services that comprised the in-
terventions tested in the study: HF-ACT, HF-ICM, scat-
tered site housing portfolio management, and congregate
housing with support.
Recruitment
Participants were recruited through service providers
and agencies serving individuals who are homeless and
mentally ill in Vancouver, including shelters, drop-in
centers, street outreach workers, hospitals, police, and
courts. An effort was made to locate individuals
throughout Vancouver, while recognizing that the major-
ity of visible homelessness and related services were
concentrated in one area.
Eligibility and level of needs
Eligible participants were Canadian citizens at least
19 years of age who met criteria for homelessness or
precarious housing and current mental disorder status.
Informed consent required that individuals were made
aware that randomization would involve assignment to
either a pre-specified intervention that included housing
or to usual care consisting of existing services and sup-
port. Participants and interviewers were therefore not
blinded to the results of randomization.
Operational definitions
Homelessness was defined as having no fixed place to
sleep or live for more than 7 nights and little likelihood of
obtaining accommodation in the coming month. Precar-
ious housing was defined as currently residing in marginal
accommodation, such as a SRO hotel, and having two or
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the past 12 months. These were minimal criteria, and par-
ticipants with more long-standing homelessness were eli-
gible for inclusion. Current mental illness was assessed
using the Mini-International Neuropsychiatric Interview
(MINI) [24] for the following: major depressive episode,
manic or hypomanic episode, post-traumatic stress dis-
order, mood disorder with psychotic features, and psych-
otic disorder. Where possible, mental disorder status was
corroborated by physician diagnosis. Participants were
categorized as moderate needs (MN) or high needs (HN).
Inclusion in the HN study was based on Multnomah
Community Ability Scale (MCAS) [25] score of 62 or
lower and current bipolar or psychotic disorder, as well as
one of the following: legal involvement in the past year,
substance dependence in the past month, and two or
more hospitalizations for mental illness in any one of the
past 5 years. All other eligible participants were included
in the MN study.
Retention strategies
A team of full-time and part-time field interviewers was
recruited to follow participants at 3-month intervals. In-
terviewers received in-depth training and supervision in
the administration of measures, and scales and items
were pre-tested with a sample of participants. Interviews
were considered ‘on time’ if they occurred within 2 weeks
of the designated anniversary date. Participants were
paid C$35 for the baseline interview and approximately
C$30 for each subsequent interview. Scales were admin-
istered verbally and responses entered immediately on
laptop computers. Major interviews conducted at 6-
month intervals required between 90 to 180 minutes to
complete in most cases. A field research office was open
daily throughout the study period, and participants were
encouraged to drop-in regardless of their interview
schedule. Interviewers obtained periodic updates regard-
ing participants’ routines and typical whereabouts, and
collateral contact information was sought in order to aid
with relocation. Interviews were conducted in various lo-
cations based on randomization arm and participant
preference, including participants’ homes, field research
office, and public settings, such as restaurants, parks,
and drop-in centers.
Randomization
After establishing eligibility for either the MN or HN
study, a computerized adaptive randomization procedure
was followed to assign participants to study arms. Inter-
viewers used laptop computers with secure live connec-
tions to upload data and receive randomization results
prior to notifying participants of the outcome. Sample
sizes of 100 participants in each study arm were derived
based on effect size estimates of 0.5 for the majoroutcome variables, power of 0.80 (β = 0.20), an attrition
rate of 40%, and significance levels of 0.05 (two-tailed).
Additional details of sample size estimates are reported
separately [1]. Based on their first 30 clients, the HF-
ACT team determined that they would be able to sup-
port no more than 90 clients, and the upper limit of this
arm was revised accordingly.
Measures
VAH researchers collaborated with investigators in four
other study centers and the study funder to develop a
common battery of repeated measures. In addition, a
number of site-specific measures were implemented at
different intervals during the study (Table 1). Both
shared and site-specific measures were selected based on
the review of existing literature and toward addressing
major gaps in knowledge. Measures were administered
at single time points if their results were historical or
highly stable (for example, adverse childhood events).
Repeated measures (for example, quality of life, commu-
nity integration) were hypothesized to be subject to vari-
ation over time based on the randomization arm, with
superior outcomes in experimental conditions compared
to treatment as usual (TAU). We similarly hypothesize
that the models of service introduced through the study
would cause superior outcomes when compared to TAU
on measures of hospitalization, emergency department
visits, and justice system involvement.
The domains addressed by the cross-site scales are:
housing and vocational status, psychiatric and physical
health, level of independent community integration and
functioning, quality of life, and use of community ser-
vices. The following questionnaires were administered at
baseline and at 6-month intervals: health service access
items (ACC) [26,27]; community integration scale (CIS)
[33]; Colorado Symptom Index (modified) (CSI) [36];
EuroQol 5D (EQ-5D) [45]; Global Appraisal of Individ-
ual Needs, Substance Problem Scale (GAIN-SPS) [50];
SF-12 Health Survey (SF-12) [72]; Quality of Life Index,
20-item (QoLI-20) [65]; social support items and food
security (FS); health, social, and justice service use inven-
tory (HSJSU); and MCAS [25]. Two instruments were ad-
ministered at 3-month intervals, Residential Time-Line
Follow-Back (RTLFB) [71] and Vocational Time-Line
Follow-Back (VTLFB) [75], to produce a continuous time-
line of housing status and vocational status, respectively.
The Recovery Assessment Scale, 22-item (RAS-22) [68]
was administered at baseline and 24 months, and the Ad-
verse Childhood Experiences (ACE) questionnaire [28]
was administered once at 18 months after baseline. A
number of other measures were implemented at a single
time-point: comorbid conditions list (CMC) [41], landlord
relations (LR), Observer-rated Housing Quality Scale
(OHQS), mobility history (MH), and core service
Table 1 Vancouver At Home (VAH) questionnaire details
Acronym Full name Timeline Key domain/topics References
ACC Health service access items BL, 6, 12, 18, 24 Use of community services: regular family physician or health
clinic use, and perceived unmet healthcare needs.
[26,27]
ACE Adverse Childhood Experiences 18 Psychiatric and physical health, traumatic early life events. [28]
CI Cognitive impairment 6, 24 Level of independent community functioning, psychiatric
and physical health: Hopkins Verbal Learning Test,
Trail Making Test, and Digit Symbol Test.
[29-32]
CIS Community integration scale BL, 6, 12, 18, 24 Level of independent community functioning, quality
of life: community participation and sense of belonging.
[33-35]
CSI Colorado Symptom Index
(modified)
BL, 6, 12, 18, 24 Psychiatric and physical health: frequency of past month’s
psychiatric symptoms.
[36-39]
CTS1 Conflict tactics scale 24 Level of independent community functioning: frequency
and severity of interpersonal conflict.
[40]
CMC Comorbid conditions list BL Psychiatric and physical health: presence of chronic
and infectious diseases.
[41]
C-SSS Core service satisfaction scale 24 Quality of life, use of community services: participant
satisfaction with services provided by Vancouver At
Home (VAH) intervention teams.
[42,43]
DSHH Demographics, housing, vocational,
and service use history
BL Housing status, use of community services: sociodemographic
details, lifetime duration of homelessness, long-term health,
social and justice service use, and vocational history.
[44]
EQ-5D EuroQol 5D BL, 6, 12, 18, 24 Psychiatric and physical health, health-related quality of life. [45-47]
FS Social support items and
food security
BL, 6, 12, 18, 24 Use of community services, psychiatric and physical health:
type, quality, availability and source of food, and recent
history of food insecurity.
[48,49]
GAIN-SPS Global Appraisal of Individual
Needs, Substance Problem Scale
BL, 6, 12, 18, 24 Substance-related problems. [50,51]
HSJSU Health, social, and justice
service use inventory
BL, 6, 12, 18, 24 Use of community services, psychiatric and physical health:
nature and frequency of health, social, and justice
system services.
[42,52-57]
III Interviewer impression items BL, 3, 6, 9, 12,
15, 18, 21, 24
Level of independent community functioning: interviewer
assessment of validity and reliability of self-report data.
LR Landlord relations 18 Housing status: specific to landlord relationship.
PHQL Perceived housing quality 6, 12, 18, 24 Housing status: subjective housing quality assessed
by participants.
[58,59]
MCAS Multnomah Community
Ability Scale
BL, 6, 12, 18, 24 Level of independent community functioning: interviewer
assessed level of functioning across range of domains.
[25,60]
MINI Mini-International Neuropsychiatric
Interview
BL Psychiatric and physical health: current major Axis I
disorders and suicidality.
[24,61-63]
MH Mobility history 21 Housing status: geographic mobility.
MoCA1 Montreal Cognitive Assessment 21 Level of independent community functioning: assessment
of cognitive domains indicated for the screening of
neurological deficits.
[64]
OHQS Observer-rated Housing Quality Scale 24 Housing status: objective ratings of physical characteristics
of participant dwellings.
PAIN1 Chronic pain screener 21 Quality of life, psychiatric and physical health.
QoLI-20 Quality of Life Index, 20-item BL, 6, 12, 18, 24 Quality of life, psychiatric and physical health: subjective
quality of life across range of domains.
[65-67]
RAS-22 Recovery Assessment Scale,
22-item
BL, 24 Quality of life, psychiatric and physical health. [68-70]
RTLFB Residential Time-Line Follow-Back 3, 6, 9, 12, 15,
18, 21, 24
Housing status: detailed chronology of housing status,
including frequency of moves, type of accommodation,
and household composition.
[39,71]
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Table 1 Vancouver At Home (VAH) questionnaire details (Continued)
SCNR Eligibility screening instrument BL Housing status, psychiatric and physical health: determines
participation eligibility based on legal adult status (>19 years
in British Columbia (BC)), absolute homelessness or precarious
housing status, and current mental illness.
[24,61-63]
SF-12 SF-12 Health Survey BL, 6, 12, 18, 24 Psychiatric and physical health, level of independent
community functioning: assessment of the extent of
impairment caused by both physical and mental illness.
[45,72,73]
VFC1 Foster care history 12 Quality of life, psychiatric and physical health: details early
life involvement in the child welfare system.
VMAP1 Maudsley Addiction Profile BL, 6, 12, 18, 24 Psychiatric and physical health: past month’s substance use,
including drug type, mode of administration, frequency
of use, and drug-related harms.
[74]
VTLFB Vocational Time-Line
Follow-Back
3, 6, 9, 12, 15,
18, 21, 24
Level of independent community functioning: detailed
chronological recent history of paid work and educational
or skills training. Quantifies income and income sources.
[75]
WAI-PAR Working Alliance Inventory,
participant
6, 12, 18, 24 Use of community services and quality of life: participant
(WAI-PAR) and service provider (WAI-PRO) assessment of
working relationship with key service provider. Assessment
of perception of client-provider relationship, support,
confidence, and trust.
[76-80]
WAI-PRO
Working Alliance Inventory,
provider
12
1Vancouver site-specific scales. Timeline: BL, baseline; 3, 3-month visit; 6, 6-month visit; 9, 9-month visit; 12, 12-month visit; 15, 15-month visit; 18, 18-month visit;
21, 21-month visit; 24, 24-month visit.
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cognitive impairment (CI) (Hopkins Verbal Learning Test,
Trail Making Test, Digit Symbol Test) [29-32], perceived
housing quality (PHQL) [58,59], and Working Alliance In-
ventory (WAI) [76-80]. Semi-structured narrative inter-
views were scheduled at baseline and 18-month time
points with approximately fifty participants (10 from each
study arm in the two VAH trials).
Site-specific measures were selected based on study
hypotheses and the anticipated characteristics of the
Vancouver homeless population. Major areas of hypoth-
esis testing were: addictions, cognitive impairment, and
psychiatric severity would negatively influence housing
stability; HF would result in superior outcomes when
compared to TAU, including reduced use of crisis ser-
vices and justice system encounters, superior housing
stability, and quality of life; and HF would produce su-
perior health outcomes compared to TAU.
The Maudsley Addiction Profile (MAP) [74] is a multi-
dimensional instrument assessing alcohol and drug use
and related harms, administered at 6-month intervals.
The Montreal Cognitive Assessment (MoCA) [64] as-
sesses several cognitive domains and is indicated for the
screening of neurological deficits in younger populations
(for example, traumatic brain injury, brain tumors, vas-
cular cognitive impairment). The foster care history
(VFC) was administered once at 12 months after base-
line. The MoCA, conflict tactics scale [40], and pain
scales (assessing acute and chronic pain; Schutz, unpub-
lished) were administered at 21 months only.
Ten participants in each study arm (n = 50) were in-
vited to participate in open-ended, qualitative interviewsplanned for baseline and 18 months after recruitment.
Participants were selected purposively in order to repre-
sent differences across gender, ethnicity, duration of
homelessness, and degree of functional impairment.
Interview questions were organized around the following
themes: pathways into and out of homelessness; high,
low, and turning points in life; and challenges and enab-
ling factors related to recovery.
In addition, fifty participants were asked to provide
consent to undergo physical health examinations involv-
ing basic physician assessment and blood analysis (for
example, hepatitis B/C, HIV/AIDS). These assessments
were included to examine the possibility of undetected
illness among members of the study cohorts. Finally, all
participants were asked to provide consent for the re-
searchers to send their identifying details to public agen-
cies in order to then receive administrative data regarding
their use of health, justice, and social welfare services (sep-
arate consent was sought for each category of agency). An
inter-agency data sharing protocol was created by a prior
project and was used as the basis for the current data ex-
tract. The fields of data specified for inclusion were: phys-
ician services; hospital services; pharmaceutical services;
community mental health and substance use services; vital
statistics; justice events, including convictions and sen-
tences; and financial assistance.
Interventions
Participants in both the MN and HN studies were ran-
domized to either an intervention based on the princi-
ples of HF or to TAU. In both studies, TAU participants
did not receive any housing or support services through
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support for individuals who are homeless and mentally
ill in Vancouver. The resources comprising TAU include
shelters, SRO hotels, and community services described
earlier. No research has previously examined the respon-
siveness and effectiveness of these services by following
a cohort of homeless individuals prospectively. Coincident
with this study, the City of Vancouver and the provincial
housing authority were in the process of expanding ser-
vices for the homeless [81]. The quality and type of hous-
ing received by participants in TAU will be carefully
documented alongside the receipt of services and support
attendant to housing. In addition to TAU, HN participants
were randomized to either HF-ACT or Congregate Hous-
ing with Support (CONG). MN participants received
either TAU or HF-ICM.
Service providers for each intervention were selected
through a competitive request for proposals. Applica-
tions were reviewed by a panel of senior individuals
drawn from homelessness research, management of ser-
vices, and community granting agencies. The criteria for
assessment included the delineation of organizational
experience, plans for implementation, and budget. Each
selected service provider received specific training in the
delivery of HF, and underwent fidelity assessments by
external review teams at two points during the study
(see below). Services were based on the model defined
by Pathways to Housing [82], including expertise that
anticipated the needs of local clients (for example, addic-
tion severity), and configured to support participants in
both scattered and congregate housing configurations.
Participants randomized to HF were transitioned to a
case manager within 2 days of study recruitment.
An inventory of apartments was developed in a variety
of neighborhoods throughout the city. These apartments
were drawn from private market rentals with numerous
landlords. In order to promote community integration, a
maximum of 20% of the units in any building could be
allocated to program participants. Consistent with the
principles of HF, participants were provided with a
choice of housing units [82]. A housing portfolio manager
was responsible for building and maintaining relationships
with landlords, including relocating participants to more
suitable locations when needed. Participants in the scat-
tered site conditions (HF-ACT and HF-ICM) received
support in their homes and were expected to meet with
program staff on a weekly basis. The CONG condition
was mounted in a single vacant hotel with the capacity to
house approximately 100 occupants in independent suites
but without full kitchens. The building was located in a
mixed residential and commercial neighborhood, adjacent
to numerous amenities. The building was equipped with a
number of facilities to support residents and to promote
the development of a positive community culture,including: central kitchen and meal area, medical examin-
ation room and formulary, and recreational areas (yoga,
basketball, road hockey, lounge). Tenants were provided
with opportunities to engage in part-time work both within
the building (for example, meal preparation, laundry) and
in the community (for example, providing a graffiti removal
service). A reception area and front desk were staffed
24 hours a day. Tenancy in any of the experimental housing
conditions was not contingent on compliance with specific
therapeutic objectives (for example, addiction treatment).
Program staff in each intervention condition participated in
a series of training events in person in order to enhance
consistency in practices. Subsidies were provided through
the study to ensure that participants paid no more than
30% of the total income on rent. Fidelity assessments were
conducted by an external team, with representatives from
Pathways to Housing, the study funder, and individuals
who had experienced homelessness. Assessments were
conducted at two time points (12 and 24 months after
implementation) using a HF fidelity scale [82], and involved
meetings with staff as well as participants in each of the HF
interventions. The assessment team provided verbal and
written feedback to the staff at each intervention.
VAH outcomes
The primary outcome domains for both trials are: hous-
ing stability, health status, quality of life, and service use.
Secondary outcome domains are: cost avoidance and
cost effectiveness. Primary outcomes will be compared
between HF and TAU, including examination of similar-
ities and differences between congregate and scattered
site configurations of HF in the HN sample. Previous re-
search has reported greater reductions in homelessness
with group housing than with placement in independent
apartments [22]. Particular attention will be paid to the
role of substance use in relation to primary outcomes.
Service use outcomes and economic analyses will be
conducted using administrative data sources as specified.
Data collection and analysis plan
Repeated measures (3- and 6-month scales) were collected
over 24 months. Based on previous studies and the results
reviewed above, approximately 2 years of follow-up was
regarded as sufficient to detect changes in the major out-
come domains. Fifteen months after commencing recruit-
ment, the cross-site protocol was shortened from 24 to
21 months. Following this change, VAH revised the com-
position of the 21-month interview in order to provide
more complete data for cross-site end point analyses;
however, VAH continued to collect data through to
24 months and preserved the original protocol as specified
in the trials’ registration. Differences between sites in the
protocol change were primarily due to differences in fi-
nancial resources between study centers. Preserving the
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important owing to the high levels of comorbidity, sub-
stance dependence, and chronicity of homelessness within
the sample.
Descriptive statistics (such as mean, median, standard
deviation, and proportions) were calculated for all quan-
titative instruments administered at baseline. Compari-
sons of variables between groups were conducted using
parametric tests (t-tests or one-way analysis of variance
(ANOVA) for continuous variables) and non-parametric
tests (Mann–Whitney or Kruskal–Wallis test for con-
tinuous variables; Pearson’s chi-squared or Fisher’s exact
tests for categorical variables), as appropriate. All re-
ported P values were two-sided.
Longitudinal analyses of VAH data were planned for
12 and 24 months using several analytic methods,
such as hierarchical linear modeling (HLM), general-
ized estimating equations (GEE), and time-to-event
analysis (such as Cox regression and negative binomial
regression), as appropriate. All longitudinal analysesFigure 1 Participant flow through eligibility, screening, needs level as
participants deemed ineligible via an informal telephone screen, and 94 parti
participants who were unable to be located after assignment or left within 1are based on intention-to-treat. The major domains of
longitudinal analysis examine the overall robustness of
interventions to promote health and recovery among
groups of participants, and investigate individual char-
acteristics that may predict different responses to in-
terventions. Planned analyses also include examination
of service use and cost outcomes using administrative
data in combination with interview results. Sensitivity
analysis will be conducted to evaluate the effect of
missing data using several methods, including mean
substitution, multiple imputations, and last observation
carried forward.
The results of narrative interviews will be analyzed ac-
cording to the organizing themes of pathways into and
out of homelessness, and high, low, and turning points
in life. These thematic analyses are expected to comple-
ment results from questionnaires. Post hoc analyses will
be informed by qualitative findings, and will also exam-
ine the characteristics of individuals who appear to exhibit
better (and worse) outcomes regardless of randomizationsessment, and allocation to study arm. αIncludes approximately 100
cipants who were ineligible after formal in-person screening. βIncludes 11
month of entering.
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formed to examine whether CONG, HF-ACT, and TAU
may be associated with better outcomes for differing
subpopulations.
Administrative data will be analyzed to provide long-
term (that is, up to 15 years prior to randomization) his-
torical perspectives on trajectories of service use prior to
and following homelessness. Administrative data will
also be used as key outcome measures (for example,
changes in hospitalization) and to validate specific items
also collected via self-report (for example, hospitalized
in past 6 months).
Data derived through the shared cross-site protocol
are owned by the study sponsor. Data that are specific to
VAH (unique instruments, administrative data) will be
retained at the host institution (Simon Fraser University,
Burnaby, BC, Canada). The use and storage of provincial
administrative data are governed by Information Sharing
Agreements between the Government of British Columbia
and Simon Fraser University. The research protocol
underwent institutional ethics review and was approved
by Simon Fraser University.
Results
Recruitment was carried out between October 2009 and
April 2011. Follow-up interviews were completed on a
schedule following each individual’s anniversary and
were completed by May 2013. Approximately 800 individ-
uals were screened by telephone. Referral sources (n = 40)
represented about thirteen different types of servicesTable 2 Follow-up status for ‘At Home’ participants after 24 m
6 months questionnaire
Study arm No follow-up1 At lea
follow
Reason Total
(n = 23)
Total
(n = 4No contact Death5 Withdrew
consent
High Needs 5 5 - 10 287
CONG (n = 107) 1 1 - 2 105
ACT (n = 90) - 1 - 1 89
HNTAU (n = 100) 4 3 - 7 93
Moderate Needs 7 4 2 13 187
ICM (n = 100) 2 1 - 3 97
MNTAU (n = 100) 5 3 2 10 90
1 - No follow-up data collected at any of 6, 12, 18 & 24 months.
2 - No significant differences between study arms was observed in terms of follow u
and 0.082 respectively).
3 - No follow-up data collected at any of 3, 6, 9, 12, 15, 18, 21 & 24 months visit.
4 - In terms of follow up completion rate, significant differences between study arm
for the MN sample (Fishers’ exact p values for HN & MN sample were 0.002 and 0.1
5 - Total number of deaths (n = 29) was as follows: CONG-4; ACT-7; HNTAU-5; ICM-6
before death and the remaining 9 participants whose follow up data was not availa
6 - Out of 29 deaths, 5 participants whose follow up data was not available died wi
least one follow up visit before death.available to homeless adults with mental illness. The ma-
jority of potential participants were referred from home-
less shelters, drop-in centers, homeless outreach teams,
hospitals, community mental health teams, and criminal
justice programs. Approximately 100 individuals were ex-
cluded via telephone due to clear ineligibility. A further
200 were excluded through the baseline interview proced-
ure due to ineligibility (n = 94), unable to contact for base-
line interview (n = 100), declining to participate (n = 3), or
incomplete interview (n = 3) (Figure 1). Of the total num-
ber of participants randomized (n = 497), 200 met criteria
for MN and 297 met criteria for HN. Retention rates by
study arm after 24 months are illustrated in Table 2. Dif-
ferent rates are indicated in relation to scales administered
every 3 months and every 6 months.
The primary reasons for loss to follow-up over
24 months were death (n = 5 for 3-month scales and n = 9
for 6-month scales) or inability to locate the participant
(n = 9 for 3-month scales and n = 12 for 6-month scales).
Some deaths occurred after participants had completed at
least one follow-up interview and these data are eligible
for analysis. The overall retention rate through 24 months
was 97% (Table 2). No significant differences between
study arms were observed in terms of follow-up (6-month
scales) completion rates (Fisher’s exact P values for HN
and MN samples were 0.074 and 0.082, respectively). For
the 3-month scales, follow-up completion rates between
HN study arms were significantly different (CONG, 100%;
HF-ACT, 100%; TAU, 94%; Fisher’s exact P value = 0.002),
but no significant difference was observed for the MNonths by need level
3 months questionnaire
st one
up2
No follow-up3 At least one
follow up4
74)
Reason Total
(n = 16)
Total
(n = 481)No contact Death6 Withdrew
consent
3 3 - 6 291
- - - - 107
- - - - 90
3 3 - 6 94
6 2 2 10 190
2 0 - 2 98
4 2 2 8 92
p completion rate (Fishers’ exact p values for HN & MN sample were 0.074
s was observed for the HN sample, but no significant difference was observed
01 respectively).
; & MNTAU-7. However, 20 participants completed at least one follow up visit
ble died with seven months of randomization.
thin five months of randomization and the rest 24 participants completed at
Table 3 Socio-demographic and mental disorder related characteristics for the ‘At Home’ participants by need status
Variables Overall N (%) HN N (%) MN N (%) P value
Socio-demographics
Age at enrolment visit (years)
Mean (SD) 40.8 (11.0) 39.7 (11.2) 42.6 (10.5) 0.004
Median (IQR) 41 (32–48) 39 (31–47) 44 (36–49) 0.002
Male Gender 359 (73) 218 (74) 141 (71) 0.420
Place of birth (Canada) 431 (87) 256 (87) 175 (88) 0.743
Ethnicity
Aboriginals 77 (16) 44 (15) 33 (16) 0.844
White 280 (56) 170 (57) 110 (55)
Other 140 (28) 83 (28) 57 (29)
Incomplete High School 280 (57) 179 (61) 101 (51) 0.022
Single (never married) 343 (70) 214 (73) 129 (65) 0.043
Have children (under18) 122 (25) 69 (24) 53 (27) 0.483
Native Language (English) 392 (80) 236 (80) 156 (78) 0.696
Homelessness
Precariously housed 109 (22) 65 (22) 44 (22) 0.976
Lifetime duration of homelessness (months)
Mean (SD) 60.2 (70.3) 62.0 (67.0) 57.5 (74.9) 0.489
Median (IQR) 36 (12–84) 42 (12–84) 36 (12–84) 0.179
Longest duration of homelessness (months)
Mean (SD) 30.9 (40.1) 32.2 (40.8) 28.9 (39.1) 0.358
Median (IQR) 12 (6–36) 18 (6–45) 12 (6–36) 0.236
Age of first homelessness (years)
Mean (SD) 30.3 (13.3) 28.7 (12.5) 32.6 (14.1) 0.002
Median (IQR) 28 (19–41) 26 (19–36) 34 (20–44) 0.003
Employment
Currently employed 18 (4) 10 (3) 8 (4) 0.722
Worked continuously (>1 year) in past 323 (65) 185 (63) 138 (69) 0.164
History of any wartime services 27 (5) 17 (6) 10 (5) 0.697
Willingness to have paid job 384 (87) 217 (84) 167 (90) 0.102
Hospitalized for mental illness (last 5 years)*
Over 6 months 57 (12) 47 (16) 10 (5) <0.001
More than two times 253 (53) 197 (69) 56 (29) <0.001
MINI International
Neuropsychiatric Interview diagnosis
Psychotic Disorder/Schizophrenia* 263 (53) 211 (71) 52 (26) <0.001
Major Depressive Episode 199 (40) 95 (32) 104 (52) <0.001
Post Traumatic Stress Disorder (PTSD) 129 (26) 63 (21) 66 (33) 0.003
Manic or Hypomanic Episode* 97 (19) 68 (23) 29 (14) 0.021
Panic Disorder 104 (21) 59 (20) 45 (22) 0.479
Mood disorder with psychotic feature 84 (17) 56 (19) 28 (14) 0.152
Substance Dependence 288 (58) 183 (62) 105 (52) 0.043
Alcohol Dependence 121 (24) 72 (24) 49 (24) 0.948
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Table 3 Socio-demographic and mental disorder related characteristics for the ‘At Home’ participants by need status
(Continued)
Suicidality (high or moderate) 168 (34) 93 (31) 75 (37) 0.153
Two or more mental disorders 240 (52) 148(53) 92 (51) 0.402
Three or more mental disorders 114 (25) 78 (28) 36 (20) 0.032
Referral sources
Shelter or transitional housing 143 (29) 82 (28) 61 (31) <0.001
Housing Lists 19 (4) 9 (3) 10 (5)
Outreach 86 (17) 44 (15) 42 (21)
Hospitals 47 (9) 35 (12) 12 (6)
Aboriginal groups 15 (3) 6 (2) 9 (4)
Criminal justice 70 (14) 59 (20) 11 (6)
Drop-in-centers 65 (13) 33 (11) 32 (16)
Mental health teams 19 (4) 13 (4) 6 (3)
Other 16 (3) 6 (2) 10 (5)
Not specified 17 (3) 10 (3) 7 (3)
* Variables used to determine eligibility for the HN sample.
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0.101). Of the 497 participants randomized, 438 (88%)
gave consent to access administrative data from publicly-
funded agencies.
Adverse events of all kinds were reported to a moni-
toring committee as well as to the Research Ethics Board
at Simon Fraser University. Apart from mortality, ad-
verse events typically involved episodes of interpersonal
conflict, such as abusive language or offensive behavior
involving participants.
Sociodemographic characteristics of participants are
detailed in Table 3. Most were male (73%), white (56%),
never married (70%), had a current medical illness (91%),
were substance dependent (58%), and met criteria for
‘absolute homelessness’ (78%).
A number of significant differences between the MN
and HN samples were observed (Table 3 and 4). Several
differences were expected based on inclusion criteria for
each study and are reflected in the results. HN partici-
pants were more likely to have a psychotic disorder, have
been hospitalized for psychiatric reasons, meet criteria for
substance dependence, and have justice system involve-
ment. HN participants also had lower MCAS scores.
Beyond differences that were directly related to inclu-
sion criteria (indicated with asterisk in Table 3 and
Table 4), a number of additional significant differences
between MN and HN were observed. MN participants
were older at recruitment and when first homeless, were
more likely to have been married, and more likely to
have completed high school than those in the HN sam-
ple. Participants in the MN sample were more likely to
report multiple physical illnesses, asthma, and HIV/
AIDS than those in the HN sample.Results of standardized questionnaires indicate broad
similarities between the MN and HN samples (Table 4).
No significant differences between groups were observed
on measures of: community integration (CIS total score),
health-related quality of life (EQ-5D), food security (FS),
overall health (SF-12, physical or mental health scores),
overall quality of life (QoLI-20), and personal recovery
(RAS-22). The MN sample reported significantly greater
physical integration in the community (CIS physical) and
a significantly lower level of externalizing or substance-
related needs (GAIN-SPS) than the HN sample.
A series of comparisons tested for potential non-
equivalence between randomization arms at baseline.
Sociodemographic and diagnostic characteristics for the
three HN and two MN study arms are shown in Table 5.
Within the HN sample, there were no significant baseline
differences of sociodemographics and mental disorders
between groups. In the MN sample, those randomized to
TAU had longer durations of homelessness (P = 0.037)
and were more likely to be absolutely homeless (P = 0.041)
at the time of recruitment. Further comparisons of ques-
tionnaire results indicate no meaningful differences be-
tween randomization arms in either the MN or HN study,
except for several comorbid medical conditions (HIV,
hepatitis B, cancer). HN participants randomized to
CONG had a significantly higher prevalence of HIV and
hepatitis B, but when all blood-borne diseases (HIV, hepa-
titis B and C) were combined, no significant differences
were observed between groups (Table 6).
Discussion
As expected, inclusion criteria led to a number of signifi-
cant differences between the MN and HN samples.
Table 4 Questionnaire related characteristics for ‘At Home’ participants by need status at enrolment visit
Questionnaire Overall mean (SD) HN mean (SD) MN mean (SD) P value
Community Integration Scale (CIS)
Physical subscale score 2.1 (1.7) 1.9 (1.7) 2.4 (1.8) <0.001
Psychological subscale score 10.9 (3.5) 11.0 (3.5) 10.7 (3.6) 0.368
Colorado Symptom Index (CSI)
Total score 37.2 (12.5) 38.0 (13.1) 36.0 (11.7) 0.098
Comorbid Conditions List (CMC)1 N (%) N (%) N (%)
Asthma 103 (21) 50 (17) 53 (26) 0.009
Hepatitis C 139 (30) 78 (28) 61 (31) 0.302
HIV/AIDS 43 (9) 18 (6) 25 (12) 0.012
Hepatitis B 25 (5) 13 (5) 12 (6) 0.412
Blood-borne infectious diseases2 157 (32) 87 (30) 70 (35) 0.224
Epilepsy or seizure 67 (13) 49 (16) 18 (9) 0.016
Stroke 27 (5) 19 (6) 8 (4) 0.248
Cancer 18 (4) 14 (5) 4 (2) 0.117
Head Injury 324 (65) 191 (64) 133 (67) 0.563
Presence of any physical illness 453 (91) 268 (90) 185 (93) 0.384
Multiple (≥ 2) physical illness 402 (81) 231 (78) 171 (86) 0.032
Multiple (≥ 3) physical illness 344 (69) 189 (64) 155 (78) 0.001
EuroQuol 5D (EQ5D)
Overall health 61.0 (22.5) 61.8 (23.1) 60.0 (21.5) 0.382
Food Security (FS)
Total score 4.6 (2.6) 4.5 (2.5) 4.8 (2.7) 0.214
Global Assessment of Individual need –Substance Problem Scale (GAIN-SPS)
Total score (last month) 2.1 (2.0) 2.3 (2.0) 1.8 (2.0) 0.007
Age of first alcohol use 14.1 (6.3) 14.2 (5.0) 14.1 (4.9) 0.751
Age of first drug use 15.7 (5.0) 15.5 (5.6) 16.0 (7.2) 0.438
Health Service Access Items (ACC)
Have a regular medical doctor 320 (65) 177 (60) 143 (72) 0.008
Place to go when you are sick 395 (81) 231 (79) 164 (83) 0.342
Needed health care, but didn’t receive it 209 (43) 129 (45) 80 (40) 0.269
Health, Social Justice Service Use Inventory (HSJSU)
Seen by a health/social service provider 389 (79) 216 (74) 173 (89) <0.001
Visited psychiatrist 134 (27) 89 (30) 45 (22) 0.066
Talked with a health/social service provider 112 (29) 58 (20) 54 (27) 0.065
Emergency room visit 281 (58) 163 (56) 118 (60) 0.483
Ambulance 195 (40) 118 (40) 77 (39) 0.748
Contacts with police (no arrest) 254 (52) 154 (53) 100 (51) 0.573
Held in a police cell (≤24 hours) 112 (23) 80 (28) 32 (16) 0.002
Arrested 173 (36) 128 (44) 45 (23) <0.001
Court appearance 174 (36) 123 (43) 51 (26) <0.001
Interviewer Impression Items (III) N (%) N (%) N (%)
Signs of difficulty in reading response card (a lot) 20 (4) 17 (6) 3 (1) 0.019
Signs of drug or alcohol intoxication (a lot) 10 (2) 7 (2) 3 (1) 0.505
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Table 4 Questionnaire related characteristics for ‘At Home’ participants by need status at enrolment visit (Continued)
Signs of psychiatric symptoms (a lot) 66 (13) 58 (19) 8 (4) <0.001
Validity of information (no confidence) 14 (3) 13 (4) 1 (<1) 0.010
Multnomah Community Ability Scale (MCAS)*
Total score 56.1 (9.6) 50.7 (6.8) 64.1 (7.3) <0.001
SF-12 Health Survey (SF-12)
Physical health 45.9 (12.3) 46.5 (12.4) 45.1 (12.2) 0.233
Mental health 35.4 (13.7) 35.8 (13.6) 34.8 (13.9) 0.445
Quality of Life Index 20 Item (QOLI-20)
Total score 73.6 (21.9) 74.4 (21.5) 72.5 (22.4) 0.337
Recovery Assessment Scale 22 item (RAS-22)
Total score 79.5 (12.0) 79.2 (11.5) 79.9 (12.8) 0.563
Maudsley Addiction Profile (MAP) N (%) N (%) N (%)
Use of alcohol 225 (46) 142 (48) 83 (42) 0.174
Use of heroin 96 (19) 59 (20) 37 (19) 0.732
Use of Cocaine 83 (17) 57 (19) 26 (13) 0.074
Use of Cocaine-crack base 160 (32) 97 (33) 63 (32) 0.805
Use of Amphetamine 61 (12) 44 (15) 17 (7) 0.035
Use of Cannabis 205 (45) 133 (47) 72 (42) 0.256
Injection drug use 88 (18) 54 (18) 34 (17) 0.727
Daily drug use (excluding alcohol) 126 (25) 82 (28) 44 (22) 0.159
Poly drug (≥ 3) use (excluding alcohol) 108 (22) 72 (24) 36 (18) 0.065
1 - Response ‘Do not know’ was considered as no.
2 - Included HIV, Hepatitis C & Hepatitis B.
* Variables used to determine eligibility for the HN sample.
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were significantly more likely to meet criteria for psych-
osis or mania/hypomania, have multiple recent psychi-
atric hospitalizations, and be severely compromised in
their community functioning. Other significant differ-
ences between MN and HN were not directly related to
the inclusion/exclusion criteria. Members of the HN co-
hort had lower educational achievement and were more
likely to have multiple mental disorders than those
assigned to the MN study. In numerous other respects,
participants assigned to MN and HN did not differ sig-
nificantly. Overall, participants were white, male, ‘abso-
lutely homeless’, physically ill, and met criteria for
substance dependence and alcohol dependence.
Participants assigned to MN were significantly more
likely to meet criteria for post-traumatic stress disorder,
major depression, and report having HIV/AIDS than
those assigned to HN. Thirty percent of the MN cohort
had been homeless for more than 60 months in their
lifetime and 26% met criteria for a psychotic disorder.
These results suggest that the descriptor ‘moderate’ is a
misnomer that understates the complexity of needs
within the MN cohort. As hypothesized, the profile of
both study cohorts (MN and HN) included level of
needs (for example, substance dependence, physicalillness) that have not been included in previous studies of
HF. VAH is therefore capable of generating new know-
ledge regarding the effectiveness of HF-ICM and HF-ACT
for clients with a broad range of presenting characteristics.
Randomization successfully minimized differences be-
tween study arms. We tested for differences on sociode-
mographic and mental health-related variables, as well
as all other measures (total score or subscale score or in-
dividual item) administered at baseline. In the MN
study, those assigned to the TAU arm were significantly
more likely to be ‘absolutely homeless’ and to have lower
lifetime duration of homelessness. No other significant
differences were observed in either study, except for
several comorbid medical conditions (HIV, hepatitis B,
cancer) with very low prevalence. HN participants ran-
domized to CONG had a significantly higher prevalence
of HIV and hepatitis B, but when all blood-borne dis-
eases (HIV, hepatitis B and C) were combined, no sig-
nificant differences were observed between groups.
Despite differences between groups, the low prevalence
of these conditions in the sample is not expected to in-
fluence results. However, tests will be designed to con-
trol for relevant differences identified at baseline.
Previous research has indicated that homeless mentally
ill individuals may have a preference for independent
Table 5 Comparisons of Socio-demographic and mental disorder related characteristics between study arms
High need (n = 297) Moderate need (n = 200)
Variable CONG
(n = 107)
N (%)
ACT
(n = 90)
N (%)
TAU
(n = 100)
N (%)
P value1 ICM
(n = 100)
N (%)
TAU
(n = 100)
N (%)
P value2
Socio-Demographics
Age at randomization (years)
Mean (SD) 40.0 (11.6) 39.5 (10.8) 39.5 (11.2) 0.910 42.1 (10.4) 43.1(10.6) 0.475
Median (IQR) 41 (30–48) 38 (31–47) 39 (32–48) 0.920 43 (34–50) 45 (36–49) 0.610
Male gender 82 (77) 66 (74) 70 (71) 0.696 71 (71) 70 (71) 0.964
Ethnicity
Aboriginals 21 (20) 11 (12) 12 (12) 0.469 19 (19) 14 (14) 0.060
Caucasian 60 (56) 53 (59) 57 (57) 60 (60) 50 (50)
Mixed/Other 26 (24) 26 (29) 31 (31) 21 (21) 36 (36)
Incomplete high school 70 (66) 47 (53) 62 (62) 0.192 56 (56) 45 (45) 0.120
Single/Never married 76 (72) 63 (70) 75 (77) 0.591 66 (66) 63 (63) 0.658
Birth country (Canada) 94 (88) 80 (89) 82 (83) 0.417 90 (90) 85 (85) 0.285
Have children (under18) 24 (23) 21 (24) 24 (25) 0.938 28 (28) 25 (25) 0.692
Native Language (English) 87 (81) 76 (84) 73 (73) 0.125 13 (13) 16 (16) 0.733
Homelessness
Absolutely homeless 88 (82) 72 (80) 72 (72) 0.179 72 (72) 84 (84) 0.041
Lifetime duration of homelessness (months)
Mean (SD) 52.2 (63.5) 61.5 (69.1) 67.6 (69.0) 0.541 68.5 (92.1) 46.4 (50.7) 0.037
Median (IQR) 36 (12–72) 42 (12–84) 48 (13–109) 0.575 48 (14–93) 24 (12–72) 0.051
Longest duration of homelessness (months)
Mean (SD) 32.9 (39.3) 30.5 (42.7) 33.0 (41.0) 0.901 31.7 (43.7) 26.0 (33.9) 0.304
Median (IQR) 20 (7–48) 12 (6–40) 12 (6–48) 0.623 48 (6–40) 12 (5–34) 0.321
Age of first homelessness (years)
Mean (SD) 29.9 (13.1) 28.0 (11.9) 28.0 (12.4) 0.474 30.8 (13.8) 34.3 (14.3) 0.083
Median (1QR) 27 (20–39) 26 (19–35) 24 (18–36) 0.463 29 (18–42) 35 (21–45) 0.118
Employment
Currently employed 5 (5) 1 (1) 4 (4) 0.368* 6 (6) 2 (2) 0.279*
Worked continuously (>1 year) in past 66 (62) 58 (69) 61 (61) 0.773 66 (66) 72 (72) 0.987
Wartime services in past 4 (4) 7 (8) 6 (6) 0.448 5 (5) 5 (5) 0.987
Willingness to have paid job 79 (82) 68 (90) 70 (82) 0.353 80 (89) 87 (91) 0.696
Hospitalized for mental illness (last 5 years)
Over 6 months 14 (13) 18 (20) 15 (15) 0.406 4 (4) 6 (6) 0.506
More than two times 73 (70) 57 (68) 67 (71) 0.927 25 (25) 31 (32) 0.299
MINI International Neuropsychiatric Interview diagnosis
Major Depressive Episode 35 (33) 31 (34) 29 (29) 0.710 52 (52) 52 (52) 1.00
Manic or Hypomanic Episode 25 (23) 23 (26) 20 (20) 0.654 11 (11) 18 (18) 0.160
Post-Traumatic Stress Disorder 27 (25) 17 (19) 19 (19) 0.445 34 (34) 32 (32) 0.802
Panic Disorder 20 (19) 15 (17) 24 (24) 0.418 19 (19) 26 (26) 0.236
Mood Disorder with psychotic feature 20 (19) 17 (19) 19 (19) 0.997 16 (16) 12 (12) 0.415
Psychotic Disorder 79 (74) 59 (66) 73 (73) 0.385 25 (25) 27 (27) 0.747
Alcohol dependence 28 (26) 19 (21) 25 (25) 0.695 25 (25) 24 (24) 0.869
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Table 5 Comparisons of Socio-demographic and mental disorder related characteristics between study arms (Continued)
Substance dependence 67 (63) 55 (61) 61 (61) 0.965 51 (51) 54 (54) 0.671
Suicidality (moderate or high) 34 (32) 28 (31) 31 (31) 0.992 33 (33) 42 (42) 0.189
Two or more mental disorders 53 (49) 41 (46) 54 (54) 0.507 44 (44) 48 (48) 0.547
Three or more mental disorders 34 (32) 22 (24) 22 (22) 0.250 17 (17) 19 (19) 0.713
Referral sources
Shelter or transitional housing 31 (29) 26 (29) 25 (25) 0.468 31 (31) 30 (30) 0.250
Housing Lists 3 (3) 4 (4) 2 (2) 6 (6) 4 (4)
Outreach 13 (12) 15 (17) 16 (16) 21 (21) 21 (21)
Hospitals 11 (10) 11 (12) 13 (13) 4 (4) 8 (8)
Aboriginal groups 2 (2) 2 (2) 2 (2) 6 (6) 3 (3)
Criminal justice 27 (25) 14 (16) 18 (18) 5 (5) 6 (6)
Drop-in-centers 15 (14) 9 (10) 9 (6) 20 (20) 12 (12)
Mental health teams 4 (4) 3 (3) 6 (6) 0 (0) 6 (6)
Other 0 (0) 1 (1) 5 (5) 4 (4) 6 (6)
Not specified 1 (1) 5 (6) 4 (4) 3 (3) 4 (4)
1 - Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.
2 - Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.
* - P value from Fisher’s Exact Test.
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[83], and that these preferences may change based on
experiences after the initiation of housing [84]. In the
present study, individuals randomized to HF-ACT had a
choice of apartments, but those randomized to CONG
were limited to selecting from among the available units
in one building. Narrative interviews will be examined in
order to assess whether participants experienced mean-
ingful differences concerning their choice of housing in
either of these two settings, and whether the experience
of choice was related to outcomes of interest.
A high percentage of participants in each study arm
(92% to 100%) were successfully followed through
24 months of interviews. Twenty-nine participants died
during the 24 months following randomization. Unsur-
prisingly, participants assigned to TAU were most likely
to be lost to follow-up during the 24 months post-
randomization. However, the differences were not statisti-
cally significant. Differences in follow-up for the 3-month
scales were significant in the HN study only. Despite sta-
tistically significant differences, the high overall follow-up
rate in each group (94% in one arm, 100% in two others)
is expected to yield valid and generalizable results. This
high follow-up rate is attributable to diverse strategies,
including extensive outreach, a welcoming field office,
relationships with service providers in the field, and main-
taining updated information regarding collateral contacts
and daily routines. More generally, the recruitment and
retention of a knowledgeable and committed team of in-
terviewers is a critical factor.
VAH shares several important methodological features
with studies in four other Canadian sites, primarily:inclusion/exclusion criteria, randomization to HF or
usual care, a common battery of cross-site measures,
and semi-structured qualitative interviews with a subset
of participants [1]. At the same time, the current study
has a number of important site-specific elements. VAH
is the only RCT to compare different configurations of
HF (congregate and scattered sites) alongside TAU. The
results of this comparison will offer guidance to many cit-
ies, including Vancouver, that include congregate varia-
tions of HF as part of their strategies to address
homelessness [85]. In addition, this trial has recruited
samples with a broader range and severity of symptoms
than those reflected in previous studies. For example, the
high prevalence of substance use disorders in this study will
help to fill a specific gap in knowledge regarding the robust-
ness of HF for individuals with concurrent disorders [86].
A number of unique measures were incorporated in
the protocol based on their expected relevance to the
local population, including measures of addiction fre-
quency and severity, neuropsychological functioning,
and physical examinations. In addition, VAH incorpo-
rates a large array of administrative data spanning di-
verse publicly-funded services and interventions across
time. These data generate opportunities to study the tra-
jectories of service involvement over 10 years prior to
recruitment in VAH, and enable follow-up of partici-
pants after the completion of the intervention. The in-
clusion of longitudinal data from multiple relevant
sectors (justice, health, financial assistance) provides a
unique opportunity for cost-based analyses.
This study combines models of housing with support
in each of the intervention conditions. This may make it
Table 6 Comparisons of questionnaire related characteristics between study arms at enrolment visit
High need (n = 297) Moderate need (n = 200)
Questionnaire CONG
(n = 107) N (%)
or Mean (SD)
ACT
(n = 90) N (%)
or Mean (SD)
TAU
(n = 100) N (%)
or Mean (SD)
P value1 ICM
(n = 100) N (%)
or Mean (SD)
TAU
(n = 100) N (%)
or Mean (SD)
P value2
Community Integration Scale (CIS)
Physical subscale score 2.1 (1.8) 1.6 (1.5) 1.8 (1.7) 0.148 2.5 (1.8) 2.4 (1.7) 0.884
Psychological subscale score 10.6 (3.7) 11.3 (3.5) 11.1 (3.2) 0.384 10.4 (3.5) 11.0 (3.6) 0.241
Colorado Symptom Index (CSI)
Total score 37.1 (13.0) 36.4 (13.4) 40.2 (12.6) 0.093 36.1 (12.2) 36.0 (11.2) 0.954
Comorbid Conditions List (CMC)3 N (%) N (%) N (%) N (%) N (%)
Asthma 18 (17) 14 (16) 18 (18) 0.904 27 (27) 26 (26) 0.873
Hepatitis C 26 (24) 23 (26) 29 (29) 0.732 32 (32) 29 (29) 0.645
HIV/AIDS 12 (11) 2 (2) 4 (4) 0.025* 16 (16) 9 (9) 0.134
Hepatitis B 9 (8) 1 (1) 3 (3) 0.039* 7 (7) 5 (5) 0.552
Blood-borne infectious diseases4 33 (32) 23 (26) 31 (32) 0.572 37 (37) 33 (33) 0.553
Epilepsy or seizure 20 (19) 10 (11) 19 (19) 0.256 5 (5) 13 (13) 0.081*
Stroke 11 (10) 2 (2) 6 (6) 0.069 2 (2) 6 (6) 0.279*
Cancer 4 (4) 1 (1) 9 (9) 0.036* 0 (0) 4 (4) 0.058*
Head Injury 66 (62) 62 (69) 63 (63) 0.544 61 (61) 72 (73) 0.079
Presence of any physical illness 98 (92) 81 (90) 89 (89) 0.818 90 (90) 95 (95) 0.179
Multiple (≥ 2) physical illness 82 (77) 69 (77) 80 (80) 0.806 84 (84) 87 (87) 0.547
Multiple (≥ 3) physical illness 69 (65) 52 (58) 68 (68) 0.334 78 (78) 77 (77) 0.866
EuroQuol 5D (EQ5D)
Overall health 59.5 (23.7) 64.2 (22.9) 62.0 (22.5) 0.361 58.4 (23.4) 61.5 (19.5) 0.325
Food Security (FS)
Total score 4.3 (2.6) 4.4 (2.6) 4.8 (2.4) 0.454 4.7 (2.8) 4.8 (2.7) 0.799
Global Assessment of Individual need –
Substance Problem Scale (GAIN-SPS)
Total score (last month) 2.4 (2.0) 2.1 (1.9) 2.3 (2.0) 0.591 1.8 (2.0) 1.8 (2.0) 0.842
Age of first alcohol use 14.3 (6.5) 14.2 (3.8) 14.2 (4.0) 0.979 13.8 (4.8) 14.3 (4.9) 0.523
Age of first drug use 15.6 (6.5) 15.3 (5.0) 15.7 (5.0) 0.892 15.4 (6.3) 16.5 (7.9) 0.304
Health Service Access Items (ACC)
Have a regular medical doctor 64 (60) 53 (59) 60 (61) 0.971 71 (71) 72 (72) 0.876
Place to go when you are sick 82 (80) 72 (81) 77 (79) 0.913 83 (84) 81 (82) 0.706
Needed health care, but didn’t receive it 45 (43) 36 (41) 48 (51) 0.371 39 (39) 41 (41) 0.817
Health, Social Justice Service Use
Inventory (HSJSU)
N (%) N (%) N (%) N (%) N (%)
Seen a health/social service provider 70 (66) 67 (75) 79 (80) 0.075 84 (84) 89 (90) 0.217
Visited psychiatrist 28 (26) 27 (30) 34 (34) 0.470 20 (20) 25 (25) 0.397
Talked a health/social service provider 12 (20) 18 (20) 19 (20) 0.992 31 (31) 23 (23) 0.218
Emergency room visit 59 (57) 51 (57) 53 (54) 0.912 64 (64) 54 (55) 0.202
Ambulance 47 (44) 33 (37) 38 (38) 0.535 35 (35) 42 (38) 0.282
Contacts with police (no arrest) 53 (52) 42 (47) 59 (60) 0.226 45 (45) 55 (56) 0.118
Held in a police cell (≤24 hours) 25 (24) 27 (31) 28 (30) 0.556 14 (14) 18 (19) 0.386
Arrested 50 (48) 32 (36) 46 (48) 0.152 19 (19) 26 (27) 0.179
Court appearance 51 (50) 34 (38) 38 (40) 0.189 22 (22) 29 (30) 0.222
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Table 6 Comparisons of questionnaire related characteristics between study arms at enrolment visit (Continued)
Interviewer Impression Items (III) N (%) N (%) N (%) N (%) N (%)
Signs of difficulty in reading card (a lot) 6 (6) 6 (7) 5 (5) 0.883 2 (2) 1 (1) 1.00*
Signs of drug or alcohol intoxication
(a lot)
1 (1) 2 (2) 4 (4) 0.349* 1 (1) 2 (2) 1.00*
Signs of psychiatric symptoms (a lot) 25 (23) 11 (12) 22 (22) 0.108 4 (4) 4 (4) 1.00*
Validity of information (no confidence) 7 (6) 4 (4) 2 (2) 0.287* 1 (1) 0 (0) 1.00*
Multnomah Community Ability
Scale (MCAS)
Total score 49.9.0 (6.7) 51.6 (6.5) 50.6 (7.0) 0.195 64.1 (7.6) 64.1 (7.1) 0.962
SF-12 Health Survey (SF-12)
Physical health 47.4 (13.1) 46.7 (12.3) 45.3 (11.6) 0.466 43.9 (12.1) 46.4 (12.9) 0.140
Mental health 34.8 (15.1) 36.9 (13.0) 35.8 (12.6) 0.551 35.7 (13.0) 33.9 (14.8) 0.371
Quality of Life Index 20 Item (QOLI-20)
Total score 72.6 (21.7) 76.2 (21.3) 74.7 (21.4) 0.497 72.2 (21.6) 72.8 (23.3) 0.851
Recovery Assessment Scale 22 item
(RAS-22)
Total score 78.2 (12.1) 80.7 (11.5) 79.1 (10.7) 0.308 80.3 (11.3) 79.5 (14.1) 0.685
Maudsley Addiction Profile (MAP) N (%) N (%) N (%) N (%) N (%)
Use of alcohol 50 (47) 44 (49) 48 (49) 0.936 37 (38) 46 (46) 0.240
Use of heroin 24 (22) 13 (14) 22 (22) 0.295 18 (18) 19 (19) 0.909
Use of Cocaine 24 (22) 14 (16) 19 (19) 0.476 12 (12) 14 (14) 0.715
Use of Cocaine-crack base 36 (34) 26 (29) 35 (36) 0.596 36 (37) 27 (27) 0.141
Use of Amphetamine 12 (11) 17 (18) 15 (15) 0.346 10 (10) 7 (7) 0.421
Use of Cannabis 46 (45) 40 (48) 47 (49) 0.848 35 (42) 37 (42) 0.960
Injection drug use 19 (18) 16 (18) 19 (20) 0.944 18 (18) 16 (16) 0.682
Daily drug use (excluding alcohol) 31 (29) 19 (21) 32 (32) 0.227 27 (27) 17 (17) 0.088
Poly drug (≥ 3) use (excluding alcohol) 30 (28) 17 (29) 25 (25) 0.318 20 (20) 16 (16) 0.421
1 -Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.
2 -Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.
2 -Response ‘Do not know’ was considered as no.
4 -Included HIV, Hepatitis C & Hepatitis B.
* -P value from Fisher’s Exact Test.
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components (for example, housing alone) that best ac-
count for any observed differences or improvements.
Each of the data sources included in the VAH protocol
is subject to sources of bias. Several questionnaires have
not been well validated with homeless mentally ill sam-
ples, and a small number were adapted or developed for
the present study. Narrative interviews with selected par-
ticipants may yield findings that are unrepresentative.
Administrative data sources are subject to limitations
that include the ability to match all subjects across all
databases, and the accuracy and completeness of the
resulting extracts. However, the combination of adminis-
trative data, narrative interviews, and questionnaires en-
ables the application of mixed-methods approaches that
enrich understanding beyond the scope of each individ-
ual data type. Finally, while other sites abbreviated their
study durations to 21 months, VAH maintained theoriginal 24-month protocol, and therefore preserved a
greater opportunity to detect changes that may require a
longer period of observation.
Conclusions
The present results confirm that VAH has successfully im-
plemented experimental protocols that promise to generate
new knowledge regarding interventions for individuals who
are both homeless and mentally ill. Participants were suc-
cessfully recruited and retained through the follow-up
period, and randomization effectively minimized differences
between study arms in each trial. Diverse data sources and
relatively long follow-up provide opportunities for multi-
method approaches to longitudinal data analysis. VAH adds
to previous research on HF by including a sample with
complex comorbidities and concurrent substance use disor-
ders, and is the first experiment to include congregate
housing alongside scattered site HF.
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